Joint

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, Doximity, Global Cord, and Lincoln Innovations and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, May 4, 2024
HireRight, Risk, Research, Complaint, HRT, Form, Risk management, Cayman, CFR, Lincoln National Corporation, Transaction, Shareholder, Advertising, Alpha, Prospectus, COVID, News, Republic, DAC, OTC, Exchange, P.C, Workforce, MD Anderson Cancer Center, Form 6-K, Joint, LNC, Zheng, VUL, Petition, Publication, Division of Tangney, Lincoln, Employment, IPO, Defendant, Organization, Umbilical cord, Policy, Hold, Security (finance), University, Register, Bank statement, Growth

For more information on the HireRight class action go to: https://bespc.com/cases/HRT

Key Points: 
  • For more information on the HireRight class action go to: https://bespc.com/cases/HRT
    Doximity operates a digital platform that provides connections between, medical information to, and patient scheduling tools for medical professionals.
  • Global Cord and Golden Meditech also maintained the same registered address in Hong Kong, even occupying the same building floor.
  • This was compared to a net income of $318 million for the third quarter of 2021 the previous year.
  • For more information on the Lincoln class action go to: https://bespc.com/cases/LNC

United Imaging to Unveil Industry-Leading MRI Advancements at ISMRM 2024

Retrieved on: 
Saturday, May 4, 2024
Pelvis, Jupiter, FDA, Brain, ADEPT, Abdomen, Radiology, HCP, Radio, Acceleration, Radiation, AI, Human Connectome Project, Heart, Software, Neuroscience, Ultra, Research, 3D, Artificial intelligence, Signal-to-noise ratio, Intelligence, Joint, ACS, UMR, MSK, Gold, MRI, Environment, Sagitta, Health, Diagnosis, 2D, Medical imaging

SHANGHAI, May 3, 2024 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will unveil its latest MRI technology, boasting incredible advancements across various fronts, as a Gold sponsor at this year's ISMRM meeting.

Key Points: 
  • SHANGHAI, May 3, 2024 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will unveil its latest MRI technology, boasting incredible advancements across various fronts, as a Gold sponsor at this year's ISMRM meeting.
  • "United Imaging has always been dedicated to pushing boundaries and driving innovation," says Dr. Al Zhang, Ph.D, Chairman & Co-CEO.
  • It transcends the traditional constraints of ultra-high-field MRI, previously confined to imaging of the brain and selected MSK joints.
  • For the "Artificial Intelligence" section, United Imaging highlights the uAIFI Technology Platform, an innovative end-to-end technology platform that revolutionizes MRI through AI-integrated hardware and software.

ColCap UK and Molo complete £300 million securitisation

Retrieved on: 
Thursday, May 2, 2024
Standard Chartered, Fitch, AAA, RMBS, AUS, COLCAP, S&P Global Ratings, Citigroup, Macquarie Group, Growth, Joint, Real estate

LONDON, May 2, 2024 /PRNewswire/ -- ColCap Financial UK Limited (ColCap UK) and Molo Tech Limited (Molo) have successfully completed their first securitisation, 'Molossus BTL 2024-1'.

Key Points: 
  • LONDON, May 2, 2024 /PRNewswire/ -- ColCap Financial UK Limited (ColCap UK) and Molo Tech Limited (Molo) have successfully completed their first securitisation, 'Molossus BTL 2024-1'.
  • The securitisation totals £300 million of prime UK buy-to-let mortgage loans in England and Wales.
  • ColCap invested in Molo, an award-winning digital buy-to-let lender, in February 2023 via its UK subsidiary, ColCap UK.
  • It sets the stage for further collaborations and growth opportunities, benefiting both our UK operations and our broader global presence, including ColCap Australia."

MASSACHUSETTS AUDITOR REPORT, TEAMSTERS SLAM UBER, LYFT WORKER MISCLASSIFICATION SCHEME

Retrieved on: 
Tuesday, April 30, 2024
Transport, Uber, State, Instacart, Commonwealth, Legislation, Food, Government, International Brotherhood of Teamsters, W-2, Joint, Big Tech, Ridesharing

BOSTON, April 30, 2024 /PRNewswire/ -- Today, Massachusetts State Auditor Diana DiZoglio released an official report documenting how companies like Uber and Lyft have cheated the state's employee protection programs out of hundreds of millions of dollars by misclassifying workers as independent contractors.

Key Points: 
  • The report, "Assessing Transportation Network Companies' Financial Obligations to Massachusetts Programs," did not include how much money worker misclassification has cost the state in other programs like food and health care assistance.
  • "The Massachusetts State Auditor's report exposes the true cost of worker misclassification.
  • Companies like Uber and Lyft are exploiting workers and taxpayers in the name of innovation and convenience,' said Teamsters General President Sean M. O'Brien.
  • The Teamsters strongly encourage all states to conduct similar audits as Massachusetts.

Humanoid Robots Move Gracefully with CCTY Technology

Retrieved on: 
Monday, April 29, 2024
COM, Engineering, Joint, Torque, Robotics, Partnership, Motion, 3D printing

LAKE ZURICH, Ill., April 29, 2024 /PRNewswire/ -- To help robot makers develop humanoid robots that emulate the mobility and flexibility of human limbs, CCTY designs and manufactures bespoke parts tailored to the unique requirements of each project.

Key Points: 
  • These critical joints must replicate the natural range of motion found in the human body, while remaining lightweight and durable.
  • "The development of humanoid robots has garnered significant attention," said Yaman Obaid, robotics engineer, CCTY.
  • "At the forefront of innovation, CCTY collaborates closely with our customers to design, develop and test application-specific humanoid robotic bearing solutions," said Nik Jerinic, strategic account manager, CCTY.
  • This partnership and expertise have enabled solutions that are making an impact on the future of the humanoid robot industry.

The Joint Corp. Reports First Quarter 2024 Financial Results

Retrieved on: 
Thursday, May 2, 2024
Sale, Element, Comp, Depreciation, Acquisition, Shareholder, Marketing, Bank statement, Adjustment, Advertising, GAAP, Joint, Pharmaceutical industry

SCOTTSDALE, Ariz., May 02, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, reported its financial results for the quarter ended March 31, 2024.

Key Points: 
  • 819 franchised clinics at March 31, 2024: Opened 23 and closed four during Q1 2024.
  • We believe working with an expert will help ensure we select the best franchisees, accelerate the process and create value for all of our stakeholders.”
    Financial Results for First Quarter Ended March 31, 2024 Compared to March 31, 2023
    Revenue was $29.7 million in the first quarter of 2024, compared to $28.3 million in the first quarter of 2023.
  • ET on Thursday, May 2, 2024 to discuss the first quarter 2024 financial results.
  • EBITDA and Adjusted EBITDA should be reviewed in conjunction with the company’s financial statements filed with the SEC.

GLOBAL CORD ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Global Cord Blood Corporation and Encourages Investors to Contact the Firm

Retrieved on: 
Friday, April 26, 2024
Person, Zheng, Umbilical cord, News, Republic, Petition, OTC, Complaint, Security (finance), Exchange, P.C, Cayman, District court, CFR, University, Defendant, Court, Transaction, MD Anderson Cancer Center, Form 6-K, Telephone, Joint

Investors have until June 21, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until June 21, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • The Company has received but rejected multiple "going private" offers, or transactions in which a public company is converted into private ownership.
  • Golden Meditech's previous financial interest in Global Cord is just one of the significant connections that have existed between the two companies during the relevant time.
  • Global Cord and Golden Meditech also maintained the same registered address in Hong Kong, even occupying the same building floor.

Plug Continues to Make Substantial Advancement in Hydrogen Generation Buildout

Retrieved on: 
Tuesday, April 23, 2024
Proton, EnergySolutions, Olin Corporation, Hydrogen, Proton-exchange membrane, PEM, TPD, Growth, Joint

LATHAM, N.Y., April 23, 2024 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the green hydrogen economy, has reached nameplate capacity at the company’s hydrogen plants in Georgia and Tennessee. With this increased supply from our hydrogen production network, Plug will benefit from a lower cost of hydrogen, a crucial step in the company’s roadmap to achieve profitable growth. This is headlined by the company’s first green hydrogen plant in Georgia already reaching nameplate capacity of 15 tons per day (TPD) of liquid hydrogen production, marking a significant milestone for Plug’s hydrogen network and the hydrogen economy in the U.S.

Key Points: 
  • Recalibrated hydrogen pricing continues to make solid progress, underscoring strategic nature of Plug’s customer relationships
    LATHAM, N.Y., April 23, 2024 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the green hydrogen economy, has reached nameplate capacity at the company’s hydrogen plants in Georgia and Tennessee.
  • With this increased supply from our hydrogen production network, Plug will benefit from a lower cost of hydrogen, a crucial step in the company’s roadmap to achieve profitable growth.
  • Plug has continued to make substantial progress on building out its North America green hydrogen network to meet customer demand.
  • In addition, the company continues to collaborate with its key hydrogen supplier in the U.S. Plug is doing substantial work on other U.S.-based plants and is actively engaged with key strategic suppliers to facilitate the expansion of its green hydrogen network and to achieve cost-effectiveness in green hydrogen production at scale.

The Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 Results

Retrieved on: 
Thursday, April 18, 2024
Joint

SCOTTSDALE, Ariz., April 18, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced it will report its first quarter 2024 financial results on Thursday, May 2, 2024, after the market close. President and CEO Peter D. Holt and CFO Jake Singleton will hold a conference call at 5:00 p.m. EDT that day to discuss the results.

Key Points: 
  • SCOTTSDALE, Ariz., April 18, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced it will report its first quarter 2024 financial results on Thursday, May 2, 2024, after the market close.
  • President and CEO Peter D. Holt and CFO Jake Singleton will hold a conference call at 5:00 p.m. EDT that day to discuss the results.
  • The live webcast of the call with accompanying slide presentation can be accessed in the IR events section https://ir.thejoint.com/events and available for approximately one year.
  • An audio archive can be accessed for one week by dialing (877) 344-7529 or (412) 317-0088 and entering conference ID 8179924.

Zylö announces the creation and spinout of Atticus Pharma Inc.

Retrieved on: 
Wednesday, April 17, 2024
Foam, CVS, Walmart, Nature, Mouse, Kroger, Skin, Joint, Intelligence, Hair loss, Ulta Beauty

GREENVILLE, SC, April 17, 2024 (GLOBE NEWSWIRE) -- Zylö recently effected a spinout of Atticus Pharma Inc., whose mission is to unlock the value of the Z-pod® topical delivery platform in the pharmaceutical vertical.

Key Points: 
  • GREENVILLE, SC, April 17, 2024 (GLOBE NEWSWIRE) -- Zylö recently effected a spinout of Atticus Pharma Inc., whose mission is to unlock the value of the Z-pod® topical delivery platform in the pharmaceutical vertical.
  • Atticus is initially focused on the Joint Development Agreement with Yuva Biosciences, whereby Atticus has the worldwide, exclusive rights to YuvaBio’s Y200™, a terminalia chebula extract, for the treatment of alopecia-related conditions and for wound-healing.
  • Beyond this initial focus on Y200-loaded Z-pods, Atticus is looking to in-license other programs, either from Zylö or from other biopharma entities.
  • Scott Pancoast, CEO + founder of Zylö and executive chairman of Atticus, stated, "By focusing on the biopharma applications of the Z-pod drug-delivery platform, Atticus can be a real force in the topical drug arena and can drive significant value for its shareholders.”